Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
From the National Centre for Research and Development in Poland:
Published in major journals, first or last author from Oslo University Hospital.
Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA(2021) Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination N Engl J Med(in press) DOI 10.1056/NEJMoa2104882, PubMed 33835768
Dueland S, Yaqub S, Syversveen T, Carling U, Hagness M, Brudvik KW, Line PD(2021) Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases JAMA Surg(in press) DOI 10.1001/jamasurg.2021.0267, PubMed 33787838
Aabel EW, Chivulescu M, Dejgaard LA, Ribe M, Gjertsen E, Hopp E, Hunt TE, Lie ØH, Haugaa KH(2021) Tricuspid Annulus Disjunction: Novel Findings by Cardiac Magnetic Resonance in Patients With Mitral Annulus Disjunction JACC Cardiovasc Imaging(in press) DOI 10.1016/j.jcmg.2021.01.028, PubMed 33744128